CareCloud, Inc. (CCLD) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance with a 9% revenue increase, improved GAAP EPS, and increased adjusted EBITDA. AI initiatives and product development show promise, with successful acquisitions enhancing market reach. The company maintains strong guidance and is strategically positioned for growth. The Q&A section reflects confidence in strategy execution and future profitability. Overall, despite some economic uncertainties and integration risks, the positive financial metrics and strategic initiatives suggest a positive stock price movement in the short term.
Key Financial Performance
Revenue for Q3 2025 $31.1 million, an increase of 9% from the same period last year. The growth is attributed to profitable growth and strategic acquisitions.
GAAP EPS for Q3 2025 Improved by $0.08 year-over-year to $0.04. This reflects operating leverage in the business model.
Adjusted EBITDA for Q3 2025 Increased 13% to $7.7 million year-over-year, demonstrating operating leverage.
Cash flow from operations for the first 9 months of 2025 $19.9 million, compared to $15.4 million in the same period last year. This increase reflects operational efficiency and financial health.
Revenue for the first 9 months of 2025 $86.1 million, compared to $82.6 million for the same period in 2024. The increase is due to business growth and acquisitions.
GAAP net income for the first 9 months of 2025 $7.9 million, compared to $4.6 million for the same period in 2024. This equates to income of $0.07 per share, reflecting improved profitability.
Non-GAAP adjusted net income for the first 9 months of 2025 $10 million or $0.24 per share, showing a year-over-year improvement.
Adjusted EBITDA for the first 9 months of 2025 $19.9 million, an increase of $3 million from $16.9 million in the same period last year, reflecting operational improvements.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Agentic AI front desk solution: A next-generation multilingual voice-driven digital assistant that autonomously manages patient calls, including appointment scheduling, prescription refills, and billing questions. It operates 24/7, integrates with CareCloud's EHR and practice management platforms, and has shown strong pilot results, handling over 70% of calls without human intervention.
Medsphere acquisition: Expanded CareCloud's reach into the hospital market, adding capabilities like inpatient EHR, emergency department systems, and hospital supply chain management. This acquisition positions CareCloud to serve the entire care continuum, from outpatient to inpatient settings.
Map App acquisition: Acquired a hospital benchmarking and performance analytics platform, enabling CareCloud to provide insights into revenue cycle metrics and tie gaps directly to its solutions. This acquisition enhances credibility and reach in hospital finance leadership.
Revenue growth: Q3 revenue increased by 9% year-over-year to $31.1 million, with adjusted EBITDA up 13% to $7.7 million, reflecting operational efficiency.
Cash flow improvement: Generated $19.9 million in cash flow from operations in the first 9 months of 2025, up from $15.4 million in the same period last year.
AI integration: Focused on embedding AI across platforms to improve clinical documentation, revenue cycle performance, and patient engagement. The AI center of excellence is driving innovation and operational efficiency.
Capital allocation: Acquired Medsphere for $16.5 million using a mix of cash and credit, with 70% of the purchase price funded from internally generated cash. The remaining balance is expected to be paid off soon, demonstrating disciplined financial management.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The company faces challenges in expanding its reach into the hospital market, which is highly competitive and often dominated by large enterprise suites. Smaller hospitals may lack the resources to adopt advanced AI-enabled capabilities, posing a barrier to growth.
Regulatory Hurdles: The integration of new acquisitions like Medsphere and Map App into CareCloud's existing operations may face compliance challenges with healthcare regulations, including HIPAA and ONC certification requirements.
Supply Chain Disruptions: The company’s expansion into hospital supply chain management through Medsphere introduces potential risks related to supply chain disruptions, which could impact service delivery and client satisfaction.
Economic Uncertainties: Economic uncertainties could affect the ability of hospitals and healthcare providers to invest in new technologies and services, potentially impacting CareCloud's revenue growth.
Strategic Execution Risks: The integration of recent acquisitions (Medsphere and Map App) poses risks related to aligning operations, achieving synergies, and meeting projected financial outcomes. Failure to effectively integrate these acquisitions could impact profitability and strategic positioning.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Full Year Revenue Guidance: CareCloud has raised its full-year revenue guidance to a range of $117 million to $119 million, up from the previous range of $111 million to $114 million.
Adjusted EBITDA Guidance: The company reaffirmed its adjusted EBITDA guidance of $26 million to $28 million.
GAAP EPS Guidance: CareCloud reaffirmed its GAAP EPS guidance of $0.10 to $0.13.
Agentic AI Front Desk Solution Launch: The company plans to formally launch its Agentic AI front desk solution in mid-December, which is expected to transform patient communication and unlock recurring revenue opportunities.
Integration of Medsphere and Map App: CareCloud is focusing on cross-selling and upselling AI-driven revenue cycle services and analytics across the Medsphere hospital footprint. The integration is expected to drive margin expansion and create a national cross-sell channel for AI and RCM automation.
AI-Driven Enhancements to Map App: The company plans to enhance the Map App with AI-driven analytics and predictive insights, transforming it into actionable intelligence for healthcare leaders.
Expansion into Hospital Market: The acquisition of Medsphere positions CareCloud to serve community hospitals, regional systems, and critical access hospitals, expanding its reach and capabilities in the hospital IT stack.
AI Center of Excellence: CareCloud aims to leverage its AI center of excellence to drive targeted automation, measurable financial benefits, and operating leverage, positioning itself as a leader in AI-enabled healthcare technology.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Preferred Stock Dividends: The GAAP net income per share for the quarter was $0.04 based on the net income attributable to common shareholders, which takes into account the preferred stock dividends.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you talk about your plan to try to win new customers and grow sales in the hospital space? What's your go-to-market strategy?
A:The strategy focuses on two primary aspects: the acquisition of Medsphere and the Map App. Medsphere expands the company's reach from ambulatory-centric services to the full care continuum, including community hospitals and acute care facilities. Map App provides analytics capabilities to enhance Medsphere's operations. The immediate priority is cross-selling and upselling AI and RCM solutions to the existing hospital base, while the secondary focus is on selling to underserved critical access hospitals.
Q:How are you thinking about the rollout of your new AI offerings?
A:The company is leveraging its domain expertise in healthcare compliance, clinical context, and interoperability standards to differentiate its AI solutions. The AI front desk solution is natively integrated into EHR and practice management platforms, offering secure, real-time access to clinical and financial data. The conversational AI has demonstrated a 70% success rate, with potential for higher rates when excluding calls transferred to human agents. The company plans to cross-sell and upsell these solutions to its expanded client base, including those from Medsphere.
Q:What are you seeing from a competitive standpoint in M&A, particularly regarding buyer and seller expectations around valuations?
A:AI is driving M&A conversations, with companies not leveraging AI facing pressure to exit. Valuations reflect this urgency. The company remains open to accretive, non-dilutive asset purchases that maintain balance sheet flexibility and offer attractive valuations. Recent acquisitions like Medsphere and Map App were structured to meet these criteria.
Q:How did the structures of the Medsphere and Map App transactions differ from prior deals, and how do you think about structuring going forward?
A:All four acquisitions this year followed a disciplined playbook: accretive, non-dilutive asset purchases with valuations of 1x or less. Medsphere was acquired for $16.5 million, with half paid in cash and the rest through a credit facility. The company has already paid off 70-75% of the balance using internally generated cash. Map App was an all-cash transaction. Future deals will follow similar principles.
Q:Do you think the acquisitions have the potential to achieve the type of margins your company has overall?
A:The company aims to achieve an operating cash flow margin of 30% or greater within three quarters for its acquisitions. Progress is being made toward this goal, and cross-selling and upselling RCM and AI solutions are expected to contribute to attractive margins.
Q:Review of Unclear Management Responses
A:None of the questions were avoided or lacked clarity. All responses were detailed and addressed the questions directly.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI capability
AI desk
Agentic AI
Care View
ChartLogic
HFMA tool
access
analytics
balance line
benchmark
benchmarking
capability Agentic
care technology
center excellence
class
collection
community
credibility
credit balance
depth capability
desk solution
dividend loss
emergency department
expansion
finance
gap
health care
hospital platform
implementation
income month
increase period
intelligence
leverage
line credit
pilot
portfolio
reach
scheduling
supply chain
CCLD Transcript
CareCloud, Inc. (CCLD) Q1 2026 Earnings Call Transcript
Positive5-7
The earnings call highlights strong financial guidance, AI product expansion, and strategic M&A plans, reflecting a positive outlook. The Q&A session supports this with positive feedback on AI products and a clear strategy for margin improvement and customer acquisition. Despite some vagueness in management responses, the overall sentiment is positive, indicating potential stock price appreciation.
CareCloud, Inc. (CCLD) Q4 2025 Earnings Call Transcript
Positive3-12
The earnings call highlights strong financial performance, with increased revenue guidance and improved cash flows. The strategic focus on AI and the successful integration of acquisitions indicate a promising future. Positive analyst sentiment in the Q&A, especially regarding AI monetization and market opportunities, supports a strong positive outlook. The company's strategic initiatives and robust financial metrics suggest a likely stock price increase exceeding 8%.
CareCloud, Inc. (CCLD) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call highlights strong financial performance with a 9% revenue increase, improved GAAP EPS, and increased adjusted EBITDA. AI initiatives and product development show promise, with successful acquisitions enhancing market reach. The company maintains strong guidance and is strategically positioned for growth. The Q&A section reflects confidence in strategy execution and future profitability. Overall, despite some economic uncertainties and integration risks, the positive financial metrics and strategic initiatives suggest a positive stock price movement in the short term.
CareCloud, Inc. (CCLD) Q2 2025 Earnings Call Transcript
Positive8-5
The earnings call summary reveals strong financial performance with positive GAAP EPS, increased adjusted EBITDA, and robust free cash flow. The company has a strategic focus on AI, enhancing product competitiveness and operational efficiency, which is positively received by customers. Despite a slight revenue decline due to a non-recurring item, the overall financial health is strong. The Q&A section supports the positive outlook with plans for growth through AI and M&A. Therefore, the stock price is likely to see a positive movement in the next two weeks.
CCLD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
